OptimizeRx (OPRX) Debt to Equity: 2010-2025
Historic Debt to Equity for OptimizeRx (OPRX) over the last 6 years, with Q3 2025 value amounting to $0.23.
- OptimizeRx's Debt to Equity fell 2542.46% to $0.23 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.23, marking a year-over-year decrease of 2542.46%. This contributed to the annual value of $0.28 for FY2024, which is 202.86% down from last year.
- OptimizeRx's Debt to Equity amounted to $0.23 in Q3 2025, which was down 2542.46% from $0.24 recorded in Q2 2025.
- OptimizeRx's 5-year Debt to Equity high stood at $0.31 for Q3 2024, and its period low was $0.23 during Q3 2025.
- In the last 3 years, OptimizeRx's Debt to Equity had a median value of $0.28 in 2023 and averaged $0.28.
- In the last 5 years, OptimizeRx's Debt to Equity tumbled by 202.86% in 2024 and then crashed by 2542.46% in 2025.
- Over the past 3 years, OptimizeRx's Debt to Equity (Quarter) stood at $0.29 in 2023, then fell by 2.03% to $0.28 in 2024, then dropped by 18.06% to $0.23 in 2025.
- Its Debt to Equity was $0.23 in Q3 2025, compared to $0.24 in Q2 2025 and $0.28 in Q1 2025.